abstract |
The present invention relates to genetically engineered recombinant RS virions and viral vectors comprising heterologous genes that can be used as vaccines. According to the present invention, recombinant RS virion vectors and viruses have been engineered to include heterologous genes including other viruses, pathogens, cellular genes, tumor antigens or to encode gene complexes of different RSV strains. |